We reduce barriers for patients accessing the medicines they need most.
Helping patients in India
Providing ophthalmology patients with unique, safe and affordable first-time offerings.
Amneal & you
Help us make healthy possible.
It takes a community
We care about the patient communities we serve.
Meeting oncology needs We reduce barriers for patients accessing the medicines they need most.
Helping patients in India Providing ophthalmology patients with unique, safe and affordable first-time offerings.
Amneal & you Help us make healthy possible.
It takes a community We care about the patient communities we serve.
We make healthy possible®
Leading forward
Our leaders talk about how Amneal has diversified beyond generics to deliver value in complex retail generics, biosimilars, injectables, specialty and international.
As of August 4, 2023, Amneal has 3 reportable business segments: 1) Generics (includes retail, injectables & biosimilars revenue), 2) Specialty and 3) AvKARE (includes distribution, government label & institutional revenue).
Our products
Our broad portfolio of approximately 270 generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
